Both in Pharmaceuticals
Corvus Pharmaceuticals vs Latigo Biotherapeutics
Over the past year CRVS returned −18.1% and LTGO returned −36.6%; their daily moves had a correlation of 0.37.
CRVS −18.1% LTGO −36.6%Growth of $1, one year, split-adjusted
| Metric | CRVS | LTGO |
|---|---|---|
| Price | $10.57 | $14.04 |
| Market cap | $889.2M | $930.8M |
| Today | +7.53% | −3.64% |
| 1 month | +0.1% | −13.7% |
| 6 months | −31.6% | — |
| Year to date | +37.3% | — |
| 1 year | +37.6% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $215.2M | — |
| Dividend yield | — | — |
| Volatility (60d) | 52.2% | — |
| Short % of float | 25.5% | 1.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).